BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21681894)

  • 1. Saphenous vein graft recanalization without embolic protection: impossible is nothing.
    Belardi JA; Albertal M
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):70-1. PubMed ID: 21681894
    [No Abstract]   [Full Text] [Related]  

  • 2. Rebuttal: Use of embolic protection devices in saphenous vein graft interventions: the ongoing challenge.
    Badhey N; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):E5-6. PubMed ID: 20853356
    [No Abstract]   [Full Text] [Related]  

  • 3. Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stent of saphenous vein grafts trial.
    Heuser RR
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):594. PubMed ID: 21351235
    [No Abstract]   [Full Text] [Related]  

  • 4. Rebuttal: innovative embolic protection strategies for saphenous vein graft interventions.
    Badhey N; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):595. PubMed ID: 21351236
    [No Abstract]   [Full Text] [Related]  

  • 5. Low frequency of embolic protection devices in saphenous vein intervention: a matter of lack of conviction?
    Lozano I; Rondan J; Avanzas P; Suarez CP
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):E4. PubMed ID: 20853360
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of the Proxis embolic protection device for guide anchoring and stent delivery during complex saphenous vein graft interventions.
    Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(3):183-7. PubMed ID: 19595401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revitalizing embolic protection in saphenous vein grafts.
    Satler LF
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):270-1. PubMed ID: 20665876
    [No Abstract]   [Full Text] [Related]  

  • 8. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saphenous vein graft interventions: drug-eluting stents are better and safe but not good enough.
    Brilakis ES; Banerjee S
    Catheter Cardiovasc Interv; 2012 May; 79(6):910-1. PubMed ID: 22511377
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous intervention of a thrombotic-occluded saphenous vein graft successfully treated using the undersized stent approach to prevent distal embolization.
    Maluenda G; Alfonso F; Pichard AD
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):65-9. PubMed ID: 21328690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proximal protection in recanalization of totally occluded saphenous vein grafts in acute coronary syndrome.
    Sganzerla P; Tavasci E
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1051-5. PubMed ID: 20146345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions.
    Rozenman Y
    JACC Cardiovasc Interv; 2011 May; 4(5):590-1; author reply 591-3. PubMed ID: 21596337
    [No Abstract]   [Full Text] [Related]  

  • 13. Are our patients better off with drug-eluting stents in saphenous vein grafts?
    Douglas JS
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1113-5. PubMed ID: 19926053
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-eluting stents for saphenous vein graft lesions.
    Hakeem A; Helmy T; Leesar M; Arif I
    JACC Cardiovasc Interv; 2011 May; 4(5):590; author reply 591-3. PubMed ID: 21596336
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidewire Self-Extrusion After Entrapment of Distal Protection Device During Saphenous Vein Graft Angioplasty.
    Wainstein RV; Homem Valle F; Pivatto JĂșnior F; Morzoletto Pedrollo I; Carlos Corsetti Bergoli L; Vugman Wainstein M
    JACC Cardiovasc Interv; 2017 Jan; 10(1):e3-e5. PubMed ID: 28017316
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of SVG disease: are we missing the point (and an opportunity)?
    Safian RD
    Catheter Cardiovasc Interv; 2012 May; 79(6):919-20. PubMed ID: 22511378
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device.
    Grow P; Rab ST
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):636-40. PubMed ID: 18942125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrograde recanalization of native coronary artery chronic occlusions via acutely occluded vein grafts.
    Brilakis ES; Banerjee S; Lombardi WL
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):109-13. PubMed ID: 19670306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombus removal prior to recanalization in vein graft occlusion intervention.
    Fung RC; Jim MH
    Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):121-123. PubMed ID: 29719982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.